RDC 658 / ANVISA
Brazil's cornerstone regulation for pharmaceutical Good Manufacturing Practices. RDC 658 mandates rigorous personnel training, competency verification, and complete documentation for every manufacturing employee.
What is RDC 658?
RDC 658/2022 is the Brazilian Health Regulatory Agency (ANVISA) resolution that establishes Good Manufacturing Practices (Boas Praticas de Fabricacao) for pharmaceutical products. Published on March 30, 2022, it replaced the previous RDC 301/2019 and aligns Brazilian pharmaceutical manufacturing standards with international benchmarks including PIC/S and WHO guidelines.
The regulation applies to all pharmaceutical manufacturers operating in Brazil, including domestic producers, international companies with local manufacturing, and contract manufacturing organizations (CMOs). It covers the entire production chain from raw material handling through finished product release.
RDC 658 places particular emphasis on personnel qualification. ANVISA inspectors routinely verify that training programs are not merely theoretical but produce measurable competency improvements. Non-compliance with training articles can result in warning letters, production shutdowns, or revocation of manufacturing authorization (Autorizacao de Funcionamento).
Who it applies to
- Pharmaceutical manufacturers in Brazil
- Contract manufacturing organizations (CMOs)
- Quality control and quality assurance teams
- Production, packaging, and warehouse personnel
Key compliance areas
- Personnel training and qualification
- Documentation and record-keeping
- Competency assessment and verification
- Periodic retraining programs
Training requirements
Articles 16 through 19 of RDC 658 establish specific, auditable training obligations for pharmaceutical manufacturers.
Article 16 — Training Requirements
All personnel whose activities may affect product quality must receive training specific to their duties. This includes not only production operators but also cleaning staff, maintenance technicians, warehouse workers, and anyone who enters controlled manufacturing areas. Training must cover GMP principles, specific standard operating procedures (SOPs) relevant to the employee's role, hygiene requirements, and contamination prevention measures.
What ANVISA auditors look for: Training records that show each employee received role-specific training before starting their duties, with clear linkage between the training content and the person's job description.
Article 17 — Competency Assessment
Training effectiveness must be assessed. It is not sufficient to demonstrate that training was delivered; the manufacturer must verify that employees actually acquired the necessary competencies. Assessment methods must be documented and may include written evaluations, practical demonstrations, or observed performance in the workplace.
What ANVISA auditors look for: Evidence of post-training evaluation with pass/fail criteria. Auditors frequently flag programs that rely solely on attendance records without any competency verification mechanism.
Article 18 — Documentation
Complete training records must be maintained and readily available for inspection. Documentation must include the training date, duration, content covered, instructor identification, attendee identification, and assessment results. Records must be stored for the retention period specified by the company's quality system, typically aligned with product shelf life plus one year.
What ANVISA auditors look for: Organized training files per employee that can be retrieved quickly during inspection. Paper-based systems with missing signatures or incomplete fields are common findings.
Article 19 — Periodic Retraining
Training must not be a one-time event. Manufacturers are required to establish a continuous training program with periodic retraining for all personnel. Retraining frequency must be defined based on risk assessment and must increase when SOPs are updated, deviations occur, new equipment is introduced, or regulatory requirements change.
What ANVISA auditors look for: A documented retraining calendar with evidence of execution. Gaps in retraining schedules, particularly after SOP revisions, are among the most common audit findings.
How Roleplays helps
Every simulation generates the documentation, scoring, and evidence trail that ANVISA requires.
Documented evidence per session
Every training session automatically generates a complete record: participant ID, date, duration, scenario content, full transcript, and evaluation scores. Satisfies Art. 18 documentation requirements without manual paperwork.
Competency scoring
Multi-criteria AI evaluation objectively measures whether an employee has acquired the required competencies. Scores map directly to Art. 17 assessment requirements, with configurable pass/fail thresholds per role and scenario.
Periodic retraining scheduling
Configure retraining cycles per role, scenario, or regulation. The platform tracks completion dates and flags overdue retraining automatically. When an SOP is updated, trigger targeted retraining for all affected employees — fulfilling Art. 19.
Audit-ready reports
Export training matrices, individual employee records, and compliance dashboards in formats ready for ANVISA inspection. Filter by date range, department, regulation, or employee. No more scrambling before an audit.
GMP scenario templates
Pre-built simulation scenarios covering contamination prevention, cleanroom procedures, deviation management, and product recall protocols. Each template is mapped to specific RDC 658 articles, ensuring training is directly tied to regulatory requirements.
Role-specific training paths
Define distinct training programs for production operators, QC analysts, warehouse staff, and management. Each path includes the specific SOPs, competencies, and assessment criteria required for that role — exactly as Art. 16 demands.
Frequently asked questions
Does Roleplays satisfy Art. 17 competency assessment requirements?
Yes. Every simulation session includes multi-criteria AI evaluation that produces objective competency scores. You can configure pass/fail thresholds per scenario, set minimum scores for each evaluation criterion, and track improvement over time. The system generates assessment records that auditors can review directly, replacing subjective evaluations with data-driven evidence.
How are training records stored and exported for ANVISA audits?
All records are stored in a database-per-tenant architecture with full encryption. You can export individual employee records, department-wide training matrices, or regulation-specific compliance reports. Exports include session date, duration, scenario ID, full transcript, evaluation criteria, scores, and pass/fail status — every field an ANVISA auditor would request per Art. 18.
Can we set up automatic retraining reminders when SOPs change?
Absolutely. You can link training scenarios to specific SOPs and regulatory articles. When content is updated, the platform automatically flags all employees who need retraining and can send notifications. Retraining cycles can be configured per role, per regulation, or per scenario — meeting Art. 19's periodic retraining mandate.
Is Roleplays suitable for production floor operators who are not tech-savvy?
Yes. Simulations use natural conversation — employees speak or type responses, just like talking to a colleague. There is no complex interface to learn. Voice-based training is available in 23 languages including Portuguese, making it accessible for all skill levels. Gamification elements like badges and leaderboards also drive engagement.
How quickly can we deploy RDC 658 training scenarios?
Roleplays includes pre-built GMP training templates that can be deployed immediately. Custom scenarios for your specific SOPs and products can be created within days, not weeks. The platform's scenario builder requires no technical skills — quality managers can create and update training content directly.
Get compliant faster.
Turn every training session into auditable evidence. Meet RDC 658 requirements with AI-powered simulations your team will actually complete.